Liz Carol Ursula Milne Bower Kees E C UR MPH PhD MBBS MSc PhD FAFPHM DLSHTM FPHA PhD Honorary Emeritus Fellow Senior Principal Research Fellow, ...

• 1. Telethon Kids Institute
• Our research
• Past teams
• Child Epidemiology

Raelene Nick Jessica Annabel Meegan Jacqueline Endersby Golding Buck Short Howlett Whitehouse R NG JB AS MH JW BSc (Hons) PhD BSc DPhil DPhil BMedRes ...

• 1. Telethon Kids Institute
• Projects

Glucocorticoids (GCs) are among the most important drugs for the treatment of acute lymphoblastic leukaemia (ALL). ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2009
• February 2009

Co-Head, Brain Tumour Research ...

• 1. Telethon Kids Institute
• Contact us
• Our people
• Staff Profiles - G

The functional effects of increased ERBB4 activation identify ERBB4 as a potential prognostic and therapeutic target ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2018
• July 2018

PhD Candidate ...

• 1. Telethon Kids Institute
• Contact us
• Our people
• Staff Profiles - S

Senior Postdoctoral Researcher ...

• 1. Telethon Kids Institute
• Contact us
• Our people
• Staff Profiles - W

Childhood brain tumors (CBT) are the leading cause of cancer death in children; their risk factors are still largely unknown. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2012
• June 2012

Standard-risk WNT medulloblastoma patients have an excellent prognosis using the combination of standard dose craniospinal radiotherapy (CSI) followed by platinum and alkylator based chemotherapy. A recent pilot study that attempted to completely omit radiotherapy was terminated early as all patients relapsed rapidly. The study highlights that therapy is the most important prognostic factor, with CSI still required to cure even the most favorable subgroup of medulloblastoma patients.  ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• December 2023

Epigenetically regulated genes have a great theranostic potential, especially in tumors with no apparent driver mutations. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2017
• October 2017